Liaoning He Eye Hospital Group Co., LTD. (SHE:301103)
China · Delayed Price · Currency is CNY 17.03
+0.01 (0.06%)
At close: Sep 30, 2026
SHE:301103 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,105 | 1,082 | 1,088 | 1,179 | 949.91 | 958.69 |
Other Revenue | 12.51 | 11.1 | 7.82 | 6.63 | 5.41 | 3.77 |
| 1,118 | 1,093 | 1,096 | 1,185 | 955.31 | 962.45 | |
Revenue Growth | 4.36% | -0.27% | -7.56% | 24.07% | -0.74% | 14.79% |
Cost of Revenue | 653.39 | 645.26 | 674.34 | 691.5 | 588.89 | 575.01 |
Gross Profit | 464.23 | 447.36 | 421.29 | 493.73 | 366.43 | 387.45 |
Selling, General & Admin | 395.33 | 379.77 | 401.11 | 392.28 | 301.73 | 251.46 |
Research & Development | 19.27 | 16.28 | 18.11 | 12.62 | 0.66 | 0.63 |
Other Operating Expenses | 6.93 | 4.58 | 7.6 | 5.82 | 5.74 | 5.09 |
Operating Expenses | 421.45 | 400.39 | 426.85 | 412.16 | 308.38 | 257.14 |
Operating Income | 42.77 | 46.97 | -5.56 | 81.57 | 58.04 | 130.3 |
Interest Expense | -7.81 | -8.77 | -11.34 | -13.6 | -12.18 | -12.1 |
Interest & Investment Income | 22.94 | 21.65 | 21.65 | 34.92 | 23.58 | 9.9 |
Currency Exchange Gain (Loss) | -0.13 | 0 | -0 | 0.06 | - | - |
Other Non Operating Income (Expenses) | -5.01 | -6.41 | -3.7 | -3.86 | -3.11 | -3.23 |
EBT Excluding Unusual Items | 52.76 | 53.43 | 1.05 | 99.09 | 66.33 | 124.87 |
Gain (Loss) on Sale of Investments | -1.3 | 0.79 | 0.99 | - | - | - |
Gain (Loss) on Sale of Assets | 0.91 | 0.75 | 1.4 | 3.53 | -0.06 | -0.31 |
Asset Writedown | -0.55 | -0.32 | -0.71 | -1.45 | -0.24 | -0.21 |
Other Unusual Items | 0.75 | 1.38 | -1.1 | 4.22 | 5.52 | 11.96 |
Pretax Income | 52.56 | 56.03 | 1.63 | 105.38 | 71.55 | 136.32 |
Income Tax Expense | 28.34 | 29.63 | 36.9 | 47.59 | 39.44 | 49.95 |
Earnings From Continuing Operations | 24.22 | 26.4 | -35.28 | 57.79 | 32.11 | 86.36 |
Minority Interest in Earnings | 0.32 | 0.93 | 7.88 | 5.76 | 0.49 | - |
Net Income | 24.55 | 27.34 | -27.4 | 63.55 | 32.59 | 86.36 |
Net Income to Common | 24.55 | 27.34 | -27.4 | 63.55 | 32.59 | 86.36 |
Net Income Growth | - | - | - | 94.99% | -62.26% | -13.84% |
Shares Outstanding (Basic) | 157 | 158 | 158 | 158 | 148 | 118 |
Shares Outstanding (Diluted) | 157 | 158 | 158 | 158 | 148 | 118 |
Shares Change | -1.24% | 0.01% | -0.00% | 6.71% | 25.10% | 0.00% |
EPS (Basic) | 0.16 | 0.17 | -0.17 | 0.40 | 0.22 | 0.73 |
EPS (Diluted) | 0.16 | 0.17 | -0.17 | 0.40 | 0.22 | 0.73 |
EPS Growth | - | - | - | 82.73% | -69.83% | -13.84% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 114.93 | 123.19 | 39.31 | -11.74 | 98.87 | 142.38 |
Free Cash Flow Per Share | 0.73 | 0.78 | 0.25 | -0.07 | 0.67 | 1.20 |
Dividend Per Share | 0.150 | 0.150 | 0.150 | 0.600 | 1.000 | 0.462 |
Dividend Growth | 0% | 0% | -75.00% | -40.00% | 116.68% | - |
Gross Margin | 41.54% | 40.94% | 38.45% | 41.66% | 38.36% | 40.26% |
Operating Margin | 3.83% | 4.30% | -0.51% | 6.88% | 6.08% | 13.54% |
Profit Margin | 2.20% | 2.50% | -2.50% | 5.36% | 3.41% | 8.97% |
Free Cash Flow Margin | 10.28% | 11.27% | 3.59% | -0.99% | 10.35% | 14.79% |
EBITDA | 89.62 | 97.31 | 51.04 | 133.63 | 109.77 | 179.92 |
EBITDA Margin | 8.02% | 8.91% | 4.66% | 11.28% | 11.49% | 18.69% |
D&A For EBITDA | 46.85 | 50.34 | 56.6 | 52.06 | 51.73 | 49.61 |
EBIT | 42.77 | 46.97 | -5.56 | 81.57 | 58.04 | 130.3 |
EBIT Margin | 3.83% | 4.30% | -0.51% | 6.88% | 6.08% | 13.54% |
Effective Tax Rate | 53.92% | 52.88% | 2267.93% | 45.16% | 55.13% | 36.64% |
Revenue as Reported | 1,118 | 1,093 | 1,096 | 1,185 | 955.31 | 962.45 |